Comments

Biohaven Stock Price, Quotes and Forecasts

Q: What sector and industry does Biohaven (BHVN) operate in?

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

BHVNNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$15.82

At close: May 16 EDT

$16.25

0.432.72%

Pre-Market: 5:22 AM EDT

Q1 2025 Earnings were released on Mon May 12th, after the market close

Biohaven (BHVN) Forecast

News Earnings Biohaven (BHVN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Biohaven Stock Price, Quotes and Forecasts | NYSE:BHVN | Benzinga

Explore Biohaven stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BHVN.

Open	-
Close	-
Volume / Avg.	958.00 / 1.70M
Day Range	- - -
52 Wk Range	14.69 - 55.70
Market Cap	$1.66B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	26
Short Interest	8.63%
Days to Cover	2.97

Recent News

Why Is Biohaven Stock Falling On Thursday?

Biohaven secures $250 million from Oberland Capital, with total cash reaching $518 million to support troriluzole launch and operations.

Vandana Singh

Red Cat Holdings, Alibaba, DXC Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland

Biohaven Ltd. (BHVN) shares rise premarket as it secures up to $600 million investment from Oberland Capital. Cash reserves expected to reach $489 million.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	958.00 / 1.70M
Day Range	- - -
52 Wk Range	14.69 - 55.70
Market Cap	$1.66B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	26
Short Interest	8.63%
Days to Cover	2.97

About Biohaven Ltd

Sector

Health Care

Industry

Biotechnology

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, an...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Biohaven (BHVN) stock?

You can purchase shares of Biohaven (NYSE:BHVN) through any online brokerage.

View our list of the best stock brokerages

Who are Biohaven (BHVN) competitors?

Other companies in Biohaven’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), ARS Pharmaceuticals (NASDAQ:SPRY), Twist Bioscience (NASDAQ:TWST), 89bio (NASDAQ:ETNB) and Centessa Pharmaceuticals (NASDAQ:CNTA).

What is the forecast, or price target, for Biohaven (BHVN) stock?

Biohaven has a consensus price target of $63.22.

What is the current price for Biohaven (BHVN)?

The stock price for Biohaven (NYSE: BHVN) is $16.25 last updated May 16, 2025 at 5:22 AM EDT.

Does Biohaven (BHVN) pay a dividend?

There are no upcoming dividends for Biohaven.

When is Biohaven (NYSE:BHVN) reporting earnings?

Biohaven’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Biohaven (BHVN) going to split?

There is no upcoming split for Biohaven.

What sector and industry does Biohaven (BHVN) operate in?

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.